BeeWell

Trials & centers

Ask your doctor

Pick a condition

Recruiting trials

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Phase 3 Recruiting

  • Clearview Cancer Institute, Huntsville, Alabama, United States
  • City of Hope, Phoenix, Arizona, United States
  • City of Hope, Duarte, California, United States
  • More sites
Official record

Collection of Circulating Biomarkers in Pancreatic Cancer

Observational Recruiting

  • Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States
Official record

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Phase 1 & 2 Recruiting

  • Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Dana Farber Cancer Institute, Boston, Massachusetts, United States
Official record

Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection

Phase 1 Recruiting

  • University of Nebraska Medical Center, Omaha, Nebraska, United States
Official record

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

Phase 2 Recruiting

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States
Official record

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Phase 1 Recruiting

  • Honor Health Research Institute, Scottsdale, Arizona, United States
  • Florida Cancer Specialists and Research Institute, Sarasota, Florida, United States
  • The University of Chicago, Chicago, Illinois, United States
  • More sites
Official record

Prehab for Pancreatic Cancer Surgery

Phase not listed Recruiting

  • UMass Memorial Medical Center, Worester, Massachusetts, United States
Official record

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Early phase 1 Recruiting

  • OHSU Knight Cancer Institute, Portland, Oregon, United States
Official record
ClinicalTrials.gov

NCI-designated centers

Comprehensive & clinical

Alabama

Arizona

California

Colorado

Connecticut

District of Columbia

  • Georgetown Lombardi Comprehensive Cancer Center

    Washington, District of Columbia

Florida

Georgia

Hawai'i

Illinois

Indiana

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana

Iowa

Kansas

Kentucky

Maryland

  • Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland

  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

    Baltimore, Maryland

Massachusetts

Michigan

Minnesota

Missouri

Nebraska

New Hampshire

New Jersey

New Mexico

  • University of New Mexico Cancer Research and Treatment Center

    Albuquerque, New Mexico

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

South Carolina

Tennessee

Texas

Utah

Virginia

Washington

  • Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium

    Seattle, Washington

Wisconsin

NCI-Designated Cancer Centers, June 10, 2026